News Frazier to stay on as Merck CEO, as company axes retirement ... Merck & Co’s CEO Ken Frazier has received the strongest possible backing from the company’s board, after it was announced the pharma company has rescinded a mandatory retirement age pol
News Pharma depriving developing countries of taxes - report A damning report by Oxfam claims that pharma giants are ‘depriving’ developing countries of millions of dollars' worth of tax money annually.
News Merck to file for new use for antibiotic Zerbaxa Antibiotic matched standard of care in phase 3 trial
News Eisai/Merck & Co's Lenvima approved in EU for first line liv... The European Commission has approved Eisai/Merck & Co's Lenvima as a new first-line treatment for liver cancer.
News Merck launches map4health diabetes mobile app App is result of 11-year collaboration with Healthy Interactions
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.